From October 1, 2022 to December 31, 2022, the company has repurchased 430,700 shares, representing 1.15% for ¥1,442.97 million. With this, the company has completed the repurchase of 705,100 shares, representing 1.89% for ¥2,376.8 million under the buyback announced on August 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,055 JPY | -2.08% | -4.68% | -6.57% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.57% | 708M | |
+31.37% | 588B | |
-2.83% | 364B | |
+20.34% | 326B | |
+5.52% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.03% | 167B | |
-0.09% | 161B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.